The largest database of trusted experimental protocols

3 protocols using ve 821

1

Detailed Inhibitor Concentrations for DNA Damage Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical inhibitors were obtained from the following suppliers and used at the indicated concentrations: KU55933 (ATMi) (Hickson et al., 2004 (link)) (118500, Millipore, 20 μM), VE-821 (ATRi) (Reaper et al., 2011 (link)) (A11605, Adooq Bioscience, 20 μM), SB218078 (Chk1i) (559402, Millipore, 5 μM), AZD7762 (Chk1/2i) (SML-0350, Sigma, 2 μM), MG-132 (Sigma, 25 μM), CHX (C7698, Sigma, 50 μM), AraC (C1768, Sigma, 50/5 μM), HAMNO (SML1234, Sigma, 20 μM), KU60019 (HY-12061, Insight Biotechnology, 10 μM), VE-822 (10 μM), AZ20 (Foote et al., 2013 (link)) (HY-15557, Insight Biotechnology, 15 μM), T2AA (SML0794, Sigma, 20 μM), KPT-251 (5005050001, Millipore, 20 μM), bortezomib (2 μM), carfilzomib (17554, Cambridge Bioscience, 2 μM), and CldU (C6891, Sigma, 5 μM).
+ Open protocol
+ Expand
2

Myocyte Differentiation and Oxidative Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydrogen peroxide mixed with a stabilizer (H2O2, Sigma) was added at various concentrations by diluting a 1 mM stock immediately before use on day 8 of myocyte differentiation after the depletion of 2ME for 1 day. N-acetylcysteine (NAC) was dissolved in water, and the pH was adjusted to 7.0. NAC was added to the cells 1 h before H2O2 stimulation. KU-55933 (Selleck Chemicals, USA), VE-821 (AdooQ BioScience, USA), NU-7441 (Selleck Chemicals), PD0325901 (Cayman Chemical, USA), SP600125 (Selleck Chemicals) and SB203580 (Sigma) were dissolved in DMSO (Sigma) and added 1 h before H2O2 stimulation. MMC was added at various concentration for 2 or 2 and a half h and then washed once and replaced with medium.
+ Open protocol
+ Expand
3

Cell Cycle Arrest and DNA Damage Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Where indicated, cells were treated with 2 mM hydroxyurea, 2.5 μm aphidicolin, 10 μm etoposide, 10 μm 5-fluorouracil, 1 μM cisplatin, 1 μM gemcitabine, 0.001 % methyl methanesulfonate, 100 nM doxorubicin, 3 μM camptothecin, 300 μM nucleosides, 10 nM afatinib, 30 nM lapatinib, 150 nM rapamycin, 15 μm MEK inhibitor U0126, 150 nM AKT inhibitor MK2206, 7.5 μm PI3K inhibitor LY294002, 1 μm ATR kinase inhibitor VE821 (AdooQ), CCT244747 (a kind gift from Prof. Ian Collins, ICR, London), 10 μm ATM kinase inhibitor KU55933 (Merck, Millipore), 100 nM UCN01 Chk1/PKCβ inhibitor (Merck, Millipore), 12.5–300 μM EmbryoMax Nucleosides (Millipore).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!